A human monoclonal antibody reactive to oxidized LDL and carbamylated LDL recognizes human and mouse atherosclerotic lesions |
Jang, Young-Ju
(Institute for Medical Science, Ajou Univ. School of Medicine)
Joo, Hee-Jae (Department of Pathology, Ajou University School of Medicine) Yang, Jeong-In (Department of Gynecology, Ajou University School of Medicine) Seo, Chang-Won (Institute for Medical Science, Ajou Univ. School of Medicine) Chung, Kui-Yea (Institute for Medical Science, Ajou Univ. School of Medicine) Lanza, Gregory M. (Department of Medicine, Cardiovascular Division, School of Medicine, Washington University in St. Louis) Zhang, Huiying (Department of Medicine, Cardiovascular Division, School of Medicine, Washington University in St. Louis) |
1 | PalinskiW, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest. 98:800-814. DOI ScienceOn |
2 | Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ,Witztum JL. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 105:1731-1740. DOI ScienceOn |
3 | Shaw PX, Horkko S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, Chen PP, Witztum JL. 2001. Humanderived antioxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to aAtherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol. 21:1333-1339. DOI ScienceOn |
4 | Schiopu A, Bengtsson J, Soderberg I, Janciauskiene S, Lindgren S, Ares MPS, Shah PK, Carlsson R, Nilsson J, Fredrikson GN. 2004. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation. 110(14):2047-2052. DOI ScienceOn |
5 | Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Harats D, George J, Levy Y, Peter JB, Motro M, Shoenfeld Y. 2001. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology. 95:20-24. DOI ScienceOn |
6 | Torzewski M, Shaw PX, Han KR, Shortal B, Lackner KJ, Witztum JL, Palinski W, Tsimikas S. 2004. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vascul Biol. 24:2307-2312. DOI ScienceOn |
7 | Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL. 2003. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am College Cardiol. 41:360-370. |
8 | Tulppala M, Ailus K, Palosuo T, Ylikorkala O. 1995. Antibodies to oxidized low-density lipoprotein and to cardiolipin in nonpregnant and pregnant women with habitual abortion. Fertil Steril. 64:947-950. DOI |
9 | Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nature Med. 13:1176-1184. DOI ScienceOn |
10 | Kakutani M, Masaki T, Sawamura T. 2000. A plateletendothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci USA. 97:360-364. DOI ScienceOn |
11 | Ok E, Basnakian AG, Apostolov OE, Barri YM, Shah SV. 2005. Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease. Kidney Int. 68:173-178 DOI ScienceOn |
12 | Kraus LM, Kraus AP Jr. 2001. Carbamoylation of amino acids and proteins in uremia. Kidney Int. 78:S102-S107. |
13 | Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO. 2009. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptordeficient mice. Circulation. 120:417-426. DOI ScienceOn |
14 | Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S. 2002. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscl Thromb Vascul Biol. 22:1649-1654. DOI ScienceOn |
15 | Osto E, Kouroedov A, Mocharla P, Akhmedov A, Besler C, Rohrer L, von Eckardstein A, Iliceto S, Volpe M, Lu¨ scher TF, Cosentino F. 2008. Inhibition of protein kinase C prevents foam cell formation by reducing scavenger receptor A expression in human macrophage. Circulation. 118:2174-2182. DOI ScienceOn |
16 | Palinski W, Ord V, Plump AS, Breslow JL, Steinberg D, Witztum JL. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 14:605-616. DOI |
17 | Goncalves I, Nitulescu M, Ares MPS, Fredrikson GN, Jansson B, Li Z-C, Nilsson J. 2009. Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions. Atherosclerosis. 205:96-100. DOI ScienceOn |
18 | Hansson GK. 2005. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352:1685-1695. DOI ScienceOn |
19 | Jain M, Sawhney H, Aggarwal N. 2004. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia. J Obstet Gynaecol Res. 30:188-192. DOI ScienceOn |
20 | Harberland ME, Fong D, Cheng L. 1988. Malondialdehydealtered protein occurs in atheroma of watanabe heritable hyperlipidemic rabbits. Science. 241:215-218. DOI |
21 | Hiki M, Shimada K, Ohmura H, Kiyanagi T, Kume A, Sumiyoshi K, Fukao K, Inoue N, Mokuno H, Miyazaki T, Daida H. 2009. Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. J Cardiol. 53:108- 116. DOI ScienceOn |
22 | Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, Witztum JL. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipidprotein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest. 103:117-128. DOI ScienceOn |
23 | Itabe H, Takeshima E, Iwasakin H, Kimuran J, Yoshidall Y, Imanaka T, Takano T. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem. 269:15274-15279. |
24 | Jeon YE, Seo CW, Yu ES, Lee CJ, Park S-G, Jang Y-J. 2007. Characterization of human monoclonal autoantibody Fab fragments against oxidized LDL. Mol Immunol. 44:827-836. DOI ScienceOn |
25 | Asci G, Basci A, Shah SV, Basnakian A, Toz H, Ozkahya M, Duman S, Ok E. 2008. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology. 13:480-486. DOI ScienceOn |
26 | Coker HA, Durham SR, Gould HJ. 2003. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol. 171:5602-5610. DOI |
27 | Basu SK, Goldstein JL, Anderson GW, Brown MS. 1976. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 73:3178-182. DOI ScienceOn |
28 | Belo L, Santos-Silva A, Quintanilha A, Rebelo I. 2008. Similarities between pre-eclampsia and atherosclerosis: A protective effect of physical exercise? Curr Med Chem. 15:2223-2229. DOI ScienceOn |
29 | Choi K, Lee HS, Chung HK. 1998. Production and characterization of monoclonal antibodies to oxidized LDL. Exp Mol Med. 30:41-45. DOI ScienceOn |
30 | Faviou E, Vourli G, Nounopoulos C, Zachari A, Dionyssiou- Asteriou A. 2005. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease. Free Radic Res. 39:419-429. DOI ScienceOn |
31 | Feng X, Yingmei Z, Ruifen X, Xie X, Tao L, Gao H, Gao Y, He Z, Wang H. 2010. Lipopolysaccharide up-regulates the expression of Fca/m receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis. 208:396-405. DOI ScienceOn |
32 | Fialova' L, Mikuli'kova' L, Malbohan I, Beneova' O, ti'pek S, Zima T, Zwinger A. 2002. Antibodies against oxidized low density lipoproteins in pregnant women. Physiol Res. 51:355-361. |
33 | Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. 1980. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA. 77:2214-2218. DOI ScienceOn |
34 | Apostolov EO, Shah SV, Ray D, Basnakian AG. 2009. Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol. 29:1622- 1630. DOI ScienceOn |
35 | Apostolov EO, Shah SV, Ok E, Basnakian AG. 2007. Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 27:826-832. DOI ScienceOn |